MAM
GILD icon

Milestone Asset Management’s Gilead Sciences GILD Stock Holding History

Milestone Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
10,514
+2,348
+29% +$309K 0.21% 108
2026
Q1 		$1.14M Sell
8,166
-40,404
-83% -$5.66M 0.21% 105
2025
Q4 		$5.96M Buy
48,570
+29,548
+155% +$3.59M 1.12% 22
2025
Q3 		$2.11M Sell
19,022
-577
-3% -$65.6K 0.4% 50
2025
Q2 		$2.17M Sell
19,599
-40,744
-68% -$4.34M 0.46% 45
2025
Q1 		$6.76M Buy
60,343
+38,066
+171% +$3.93M 1.44% 12
2024
Q4 		$2.06M Buy
22,277
+7,513
+51% +$676K 0.45% 57
2024
Q3 		$1.24M Sell
14,764
-7,413
-33% -$566K 0.28% 76
2024
Q2 		$1.52M Buy
22,177
+9,916
+81% +$662K 0.38% 51
2024
Q1 		$898K Buy
+12,261
New +$943K 0.26% 78

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Milestone Asset Management's GILD Position: Q2 2026 in Review

Milestone Asset Management increased its Gilead Sciences (GILD) stake by 29% in Q2 2026, buying an estimated $309K and bringing the position to 10,514 shares worth $1.33M. The position accounts for 0.21% of the portfolio, ranked #108.

Milestone Asset Management first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.76M in Q1 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Milestone Asset Management held 10,514 shares of Gilead Sciences worth $1.33M as of Q2 2026.
  • Milestone Asset Management bought 2,348 Gilead Sciences shares in Q2 2026, an estimated $309K.
  • Gilead Sciences made up 0.21% of Milestone Asset Management's portfolio in Q2 2026, its #108 holding.
  • Milestone Asset Management first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
  • Milestone Asset Management's Gilead Sciences position peaked at $6.76M in Q1 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Milestone Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.